Amgen (AMGN) Dividends Paid - Common (2011 - 2026)
Amgen (AMGN) posted quarterly Dividends Paid - Common of $1.4 billion for Q1 2026, up 6.18% year-over-year from $1.3 billion in Q1 2025, and up 5.85% quarter-over-quarter from $1.3 billion in Q4 2025.
Amgen (AMGN) Dividends Paid - Common (2011 - 2026) Analysis & Trends
Amgen's Dividends Paid - Common history runs 16 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- In Q1 2026, Dividends Paid - Common rose 6.18% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $5.2 billion (up 6.12% YoY), while the FY2025 annual figure was $5.1 billion, up 6.04% from the prior year.
- Dividends Paid - Common for Q1 2026 stood at $1.4 billion, up from $1.3 billion in the prior quarter.
- The five-year high for Dividends Paid - Common was $1.4 billion in Q1 2026, with the low at $1.0 billion in Q2 2022.
- The 5-year median for Dividends Paid - Common is $1.2 billion (2024), against an average of $1.2 billion.
- The sharpest annual moves came in 2022 and 2023: Dividends Paid - Common rose 2.98% in 2022, then rose 9.83% in 2023.
- Amgen's Dividends Paid - Common stood at $1.0 billion in 2022, then climbed by 9.62% to $1.1 billion in 2023, then grew by 5.7% to $1.2 billion in 2024, then rose by 6.47% to $1.3 billion in 2025, then grew by 5.85% to $1.4 billion in 2026.
- Business Quant data shows AMGN's Dividends Paid - Common at $1.4 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 2.87 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.58 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.03 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 Bn |
| Jun 30, 2026 | 1.36 Bn |
| Mar 31, 2026 | 1.36 Bn |
| Mar 31, 2026 | 1.36 Bn |
| Dec 31, 2025 | 1.28 Bn |
| Dec 31, 2025 | 1.28 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Dec 31, 2024 | 1.21 Bn |
| Dec 31, 2024 | 1.21 Bn |
| Sep 30, 2024 | 1.21 Bn |
| Sep 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Mar 31, 2024 | 1.21 Bn |